Number of observations | MR per 1000 PYRS (deaths/PYRS) | HR (95% CI)a | Number of observations with a seen vaccination card within 12 months after visit | Measles Vaccinated during follow up | DTP Vaccinated during follow up | |
---|---|---|---|---|---|---|
All children | ||||||
Measles unvaccinated | 9440 | 65.5 (272/4155) | 1 (ref) | 5825 | 48% (2767/5825) | 30% (1721/5825) |
Measles vaccinated | 22,285 | 44.9 (441/9811) | 0.76 (0.63–0.91) | 16,535 | 3% (532/16535) | 10% (1580/16535) |
Early age (< 274 days)b | 5740 | 41.9 (106/2528) | 0.68 (0.53–0.87) | 4096 | 4% (183/4096) | 10% (424/4096) |
Recommended age (274–365 days) b | 9706 | 44.3 (188/4245) | 0.77 (0.62–0.96) | 7027 | 3% (201/7027) | 7% (489/7027) |
Late (366–735 days) b | 6839 | 48.4 (147/3038) | 0.86 (0.67–1.11) | 5412 | 3% (148/5412) | 12% (667/5412) |
Boys | ||||||
Measles unvaccinated | 4782 | 63.7 (134/2104) | 1 (ref) | 2943 | 47% (1385/2943) | 28% (832/2943) |
Measles vaccinated | 11,345 | 46.2 (231/4995) | 0.79 (0.62–1.00) | 8505 | 3% (270/8505) | 10% (814/8505) |
Early age (< 274 days) b | 2936 | 48.1 (62/1290) | 0.79 (0.57–1.08) | 2074 | 4% (85/2074) | 11% (228/2074) |
Recommended age (274–365 days)b | 4959 | 42.8 (93/2170) | 0.75 (0.56–1.00) | 3636 | 3% (107/3636) | 7% (254/3636) |
Late (366–735 days)b | 3450 | 49.5 (76/1535) | 0.89 (0.64–1.22) | 2795 | 3% (78/2795) | 12% (332/2795) |
Girls | ||||||
Measles unvaccinated | 4658 | 67.3 (138/2051) | 1 (ref) | 2882 | 48% (1382/2882) | 31% (889/2882) |
Measles vaccinated | 10,940 | 43.6 (210/4816) | 0.73 (0.57–0.93) | 8030 | 3% (262/8030) | 10% (766/8030) |
Early age (< 274 days)b | 2804 | 35.5 (44/1238) | 0.57 (0.40–0.81) | 2022 | 5% (98/2022) | 10% (196/2022) |
Recommended age (274–365 days)b | 4747 | 45.8 (95/2075) | 0.79 (0.59–1.05) | 3391 | 3% (94/3391) | 7% (235/3391) |
Late (366–735 days)b | 3389 | 47.2 (71/1503) | 0.83 (0.60–1.15) | 2617 | 3% (70/2617) | 13% (335/2617) |